Resolve Biosciences is applying the power of Molecular Cartography™ to enable scientists to gain new insights based on the highest-resolution view of single-cell spatial biology. The platform features the company's proprietary, multiplexed, single-molecule detection technology, which offers full spatial context at subcellular resolution, all in a workflow that preserves the sample tissue. The platform offers unparalleled sensitivity and specificity that helps scientists detect individual transcripts and rare signals to interpret fundamental biology and rapidly advance the understanding of complex biological questions in critical fields such as oncology, neuroscience, and infectious disease. The technology has been under development since 2016 and is currently available through an oversubscribed early access program.


Biotechnology

Research

Resolve Biosciences

John Stark

Yu-chen Jenny Chen

Andreas Stockter

Armela Naçi

Hüseyin T.

Todd Pollard

Kieren Patel, Ph.D., M.B.A., Esq.

Kieren Patel

Laura Klitten

Viola Gielen

Kim R.

Axel Heinemann

Frank Zhong

The Leadership Team at Resolve Biosciences drives the company's strategic vision and operational excellence, guiding the development and commercialization of its innovative Molecular Cartography™ technology. Comprising key executives with expertise in business development, scientific research, and corporate strategy, the team fosters collaboration across disciplines to advance understanding of single-cell spatial biology and ensure the technology meets the evolving needs of scientists in critical fields such as oncology and neuroscience. Their collective leadership aims to position Resolve Biosciences as a pioneer in molecular detection and spatial biology solutions.

Leadership Team

Engineering and Development Team

Leadership Team

About

Team members

Other teams at Resolve Biosciences

Engineering and Development Team